Why is Prophylactic Anticoagulation Important in Cancer Patients?
Cancer patients are at a heightened risk for VTE due to multiple factors including the [type of cancer](), the stage of the disease, and the treatments being administered. Thrombotic events can lead to serious complications such as pulmonary embolism, which can be life-threatening. Therefore, prophylactic anticoagulation in these patients aims to prevent such events, improve quality of life, and potentially enhance overall survival.
